Current use for old antibacterial agents: polymyxins, rifampin, and aminoglycosides

被引:13
作者
Kaye, D [1 ]
机构
[1] Drexel Univ, Coll Med, Dept Med, Philadelphia, PA 19129 USA
关键词
D O I
10.1016/j.idc.2004.04.007
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
This article discusses three classes of antibacterial agents that are uncommonly used in bacterial infections (other than mycobacterial infections) and can be thought of as special-use agents. These are the polymyxins, rifampin, and the aminoglycosides.
引用
收藏
页码:669 / +
页数:22
相关论文
共 107 条
[31]   Effectiveness and safety of once-daily aminoglycosides: A meta-analysis [J].
FerriolsLisart, R ;
AlosAlminana, M .
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 1996, 53 (10) :1141-1150
[32]   Rifampin and Rifabutin drug interactions - An update [J].
Finch, CK ;
Chrisman, CR ;
Baciewicz, AM ;
Self, TH .
ARCHIVES OF INTERNAL MEDICINE, 2002, 162 (09) :985-992
[33]   Killing activities of trovafloxacin alone and in combination with β-lactam agents, rifampin, or vancomycin against Streptococcus pneumoniae isolates with various susceptibilities to extended-spectrum cephalosporins at concentrations clinically achievable in cerebrospinal fluid [J].
Fitoussi, F ;
Doit, C ;
Geslin, P ;
Bingen, E .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (10) :2372-2375
[34]  
Freeman CD, 1996, PHARMACOTHERAPY, V16, P1093
[35]   EVALUATION OF ANTIMICROBIAL REGIMENS FOR TREATMENT OF EXPERIMENTAL PENICILLIN-RESISTANT AND CEPHALOSPORIN-RESISTANT PNEUMOCOCCAL MENINGITIS [J].
FRIEDLAND, IR ;
PARIS, M ;
EHRETT, S ;
HICKEY, S ;
OLSEN, K ;
MCCRACKEN, GH .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1993, 37 (08) :1630-1636
[36]  
FRIEDLAND IR, 1994, NEW ENGL J MED, V331, P377, DOI 10.1056/NEJM199408113310607
[37]   POLYMYXIN-B SULFATE MODIFICATION OF BACTERIAL-ENDOTOXIN - EFFECTS ON THE DEVELOPMENT OF ENDOTOXIN-SHOCK IN DOGS [J].
FROM, AHL ;
FONG, JSC ;
GOOD, RA .
INFECTION AND IMMUNITY, 1979, 23 (03) :660-664
[38]   Contemporary assessment of antimicrobial susceptibility testing methods for polymyxin B and colistin: Review of available interpretative criteria and quality control guidelines [J].
Gales, AC ;
Reis, AO ;
Jones, RN .
JOURNAL OF CLINICAL MICROBIOLOGY, 2001, 39 (01) :183-190
[39]  
GALLOE AM, 1995, EUR J CLIN PHARMACOL, V48, P39
[40]   Treatment of multidrug-resistant Acinetobacter baumannii ventilator-associated pneumonia (VAP) with intravenous colistin:: A comparison with imipenem-susceptible VAP [J].
Garnacho-Montero, J ;
Ortiz-Leyba, C ;
Jiménez-Jiménez, FJ ;
Barrero-Alodóvar, AE ;
García-Garmendia, JL ;
Bernabeu-Witteli, M ;
Gallego-Lara, SL ;
Madrazo-Osuna, J .
CLINICAL INFECTIOUS DISEASES, 2003, 36 (09) :1111-1118